Reporte zur Charge EER8730

Symptomtext

36 hours after my shot I experience a mild frontal headache; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EER8730) via an unspecified route of administration in the right arm on 25Apr2021 at 12:30 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 04Apr2021 at 12:00 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. On 26Apr2021 at 00:00, 36 hours after shot, the patient experienced mild frontal headache which lasted most of the day until after dinner. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mild frontal headache was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.